Microglial activation and age-related dopaminergic neurodegeneration in MPTP-treated SAMP8 mice
- 1 July 2010
- journal article
- Published by Elsevier BV in Brain Research
- Vol. 1345, 213-220
- https://doi.org/10.1016/j.brainres.2010.05.043
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonismNeurobiology of Disease, 2007
- Toxin-induced models of Parkinson’s diseaseNeuroRX, 2005
- Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanismProgress in Neurobiology, 2005
- Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatumBrain Research, 2001
- Adaptive changes in the nigrostriatal pathway in response to increased 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced neurodegeneration in the mouseEuropean Journal of Neuroscience, 2000
- Deficiency of Inducible Nitric Oxide Synthase Protects Against MPTP Toxicity In VivoJournal of Neurochemistry, 2000
- Compensatory mechanisms in experimental and human Parkinsonism: towards a dynamic approachProgress in Neurobiology, 1998
- MPTP‐induced oxidative stress and neurotoxicity are age‐dependent: Evidence from measures of reactive oxygen species and striatal dopamine levelsSynapse, 1994
- Oxidative Stress, Glutamate, and Neurodegenerative DisordersScience, 1993
- COGNITIVE IMPAIRMENT IN EARLY, UNTREATED PARKINSON'S DISEASE AND ITS RELATIONSHIP TO MOTOR DISABILITYBrain, 1991